International Clinical Trial: SCTB35 and SCTB41 With or Without Chemotherapy in Non-Hodgkin Lymphoma

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07819188) titled 'SCTB35 and SCTB41 With or Without Chemotherapy in Non-Hodgkin Lymphoma' on Sept. 8.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Sinocelltech Ltd.

Condition: NHL - Non-Hodgkin's Lymphoma

Intervention: Drug: SCTB35 injection

Recruitment Status: Not recruiting

Phase: Phase 1/Phase 2

Date of First Enrollment: September 30, 2026

Target Sample Size: 90

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07819188

Published by HT Digital Cont...